Paper - WANFANG MED ONLINE

You Position: Home > Paper

色素失禁症的眼部表现及治疗

( views:679, downloads:621 )

Author:: No author available

Journal Title:: Chinese Journal of Ocular Fundus Diseases

Issue:: 3

DOI:: 10.3760/cma.j.issn.1005-1015.2015.03.028

Key Word:: 色素失调症/并发症;视网膜疾病/诊断;视网膜疾病/治疗;综述

Abstract：色素失禁症(IP)是一种临床较少见的X染色体显性遗传病,主要侵犯皮肤、牙齿、眼睛、神经系统及骨骼.视力丧失及中枢神经系统症状是其严重临床表现.眼部特征性表现为视网膜血管异常及视网膜色素上皮改变.IP及其眼部病变诊断主要是根据其临床表现、皮肤病理改变及基因分析.全身病变治疗主要为对症.眼部病变治疗可视情况分别采用激光光凝、冷冻、抗血管内皮生长因子药物及玻璃体切割手术.认识IP及其眼部病变的临床特征,重视科间合作,及时、规范的眼底检查以及早期诊断治疗有助于保护患者视功能.

Reference

[1]樊子川,张萍,杨琳,等.色素失禁症临床表型与NEMO基因突变7例并文献复习[J].2013,(3).
[2]李莉,宋国维,杜军保,等.色素失禁症NEMOΔ4~10基因片段缺失的初步研究[J].2005,(2).
[3]朱雪梅,梁建宏,黎晓新.抗血管内皮生长因子药物治疗皮肤色素失禁症相关性视网膜病变一例[J].2015,(1).
[4]M F, Goldberg.Macular vasculopathy and its evolution in incontinentia pigmenti.[J].1998,19(3).
[5]K J, Wald,M C, Mehta,O, Katsumi,etc.Retinal detachments in incontinentia pigmenti.[J].1993,111(5).
[6]Carolyn A, Cates,Samantha S, Dandekar,Declan W, Flanagan,etc.Retinopathy of incontinentia pigmenti: a case report with thirteen years follow-up.[J].2003,24(4).
[7]Sanghi, Gaurav,Dogra, Mangat R.,Ray, Munni,etc.Predominant exudative retinopathy in incontinentia pigmenti and clinical course after peripheral laser photocoagulation.[J].2011,59(3).
[8]Saad, Shaikh,Michael T, Trese,Steven M, Archer.Fluorescein angiographic findings in incontinentia pigmenti.[J].2004,24(4).
[9]Figen Batioglu,Emin Ozmert.Early indirect laser photocoagulation to induce regression of retinal vascular abnormalities in incontinentia pigmenti[J].2010,88(2).
[10]Y S, Yu,B J, Cho.Cryotherapy for retinopathy of incontinentia pigmenti.[J].1991,5(1).
[11]J, Rahi,J, Hungerford.Early diagnosis of the retinopathy of incontinentia pigmenti: successful treatment by cryotherapy.[J].1990,74(6).
[12]M F, Goldberg.The blinding mechanisms of incontinentia pigmenti.[J].1994,15(2).
[13]Alexander L, Berlin,Amy S, Paller,Lawrence S, Chan.Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.[J].2002,47(2).
[14]G K, Shah,C G, Summers,A W, Walsh,etc.Optic nerve neovascularization in incontinentia pigmenti.[J].1997,124(3).
[15]Miano MG,Israel A,Fusco F,etc.Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.[J].2004,13(16).
[16]G H, FINDLAY.On the pathogenesis of incontinentia pigmenti, with observations on an associated eye disturbance resembling retrolental fibroplasia.[J].1952,64(4).
[17]Minic S,Obradovic M,Trpinac D,etc.Clinical features of incontinentia pigmenti with emphasis on oral and dental abnormalities.[J].2006,10(4).
[18]Claudia, Jandeck,Ulrich, Kellner,Michael H, Foerster.Successful treatment of severe retinal vascular abnormalities in incontinentia pigmenti.[J].2004,24(4).
[19].NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients[J].2013,40(4).
[20]R A, Catalano,M, Lopatynsky,W S, Tasman.Treatment of proliferative retinopathy associated with incontinentia pigmenti.[J].1990,110(6).
[21]Esposito T,Smahi A,Munnich A,etc.A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.[J].2001,10(19).
[22]Parag K, Shah,Sandeep, Bachu,Venkatapathy, Narendran,etc.Intravitreal bevacizumab for incontinentia pigmenti.[J].2013,50 Online.
[23]Samara Silva, Kouzak,Marcela Sena Teixeira, Mendes,Izelda Maria Carvalho, Costa.Cutaneous mosaicisms: concepts, patterns and classifications.[J].1900,88(4).
[24]O'Doherty M,Green AJ,Brosnahan D,etc.Incontinentia pigmenti--ophthalmological observation of a series of cases and review of the literature.[J].2011,95(1).
[25]Cláudia Schermann, Poziomczyk,Júlia Kanaan, Recuero,Luana, Bringhenti,etc.Incontinentia pigmenti.[J].1900,89(1).
[26]C A, Brown.Incontinentia pigmenti: the development of pseudoglioma.[J].1988,72(6).
[27]P R, Cohen.Incontinentia pigmenti: clinicopathologic characteristics and differential diagnosis.[J].1994,54(3).
[28]O, Mensheha-Manhart,M M, Rodrigues,J A, Shields,etc.Retinal pigment epithelium in incontinentia pigmenti.[J].1975,79(4).
[29]M F, Goldberg,P H, Custis.Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome).[J].1993,100(11).
[30]Hirose T,Lou PL,Ryan EA,etc.Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition.[J].2009,24(2).
[31]R C, Ferreira,L C, Ferreira,L, Forstot,etc.Corneal abnormalities associated with incontinentia pigmenti.[J].1997,123(4).
[32]R G, Carney.Incontinentia pigmenti. A world statistical analysis.[J].1976,112(4).
[33]Minic Snezana,Obradovic Miljana,Kovacevic Igor,etc.Ocular anomalies in incontinentia pigmenti: Literature review and meta-analysis[J].2010.
[34]A, Smahi,G, Courtois,P, Vabres,etc.Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.[J].2000,405(6785).
[35]B, Smith,E H, Bedrossian.Incontinentia pigmenti associated with nasolacrimal duct obstruction.[J].1984,15(12).
[36]J, Fran?ois.Incontinentia pigmenti (Bloch-Sulzberger syndrome) and retinal changes.[J].1984,68(1).
[37]Nguyen JK,Brady Mccreery KM.Laser photocoagulation in preproliferative retinopathy of incontinentia pigmenti.[J].2001,5(4).
[38]S J Landy,D Donnai.Incontinentia pigmenti (Bloch-Sulzberger syndrome).[J].1993,30(1).
[39]Theresa R. Pacheco,Moise Levy,James C. Collyer,etc.Incontinentia pigmenti in male patients[J].2006,55(2).
[40]G, Holmstr?m,K, Thorén.Ocular manifestations of incontinentia pigmenti.[J].2000,78(3).
[41]P R, Cohen,R, Kurzrock.Miscellaneous genodermatoses: Beckwith-Wiedemann syndrome, Birt-Hogg-Dube syndrome, familial atypical multiple mole melanoma syndrome, hereditary tylosis, incontinentia pigmenti, and supernumerary nipples.[J].1995,13(1).